MetLife Inc
NYSE:MET
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
MetLife Inc
NYSE:MET
|
US |
|
Apellis Pharmaceuticals Inc
NASDAQ:APLS
|
US |
|
Toyo Seikan Group Holdings Ltd
TSE:5901
|
JP |
|
I
|
IDFC First Bank Ltd
BSE:539437
|
IN |
|
Coats Group PLC
LSE:COA
|
UK |
|
H
|
Hochtief AG
F:HOT
|
DE |
|
K
|
KRN Heat Exchanger and Refrigeration Ltd
NSE:KRN
|
IN |
|
S
|
Surgepays Inc
NASDAQ:SURG
|
US |
|
T
|
Transurban Group
OTC:TRAUF
|
AU |
|
COSCO Shipping Energy Transportation Co Ltd
SSE:600026
|
CN |
Wall St Price Targets
MET Price Targets Summary
MetLife Inc
According to Wall Street analysts, the average 1-year price target for MET is 93.78 USD with a low forecast of 73.92 USD and a high forecast of 111.3 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MET's stock price target?
Price Target
93.78
USD
According to Wall Street analysts, the average 1-year price target for MET is 93.78 USD with a low forecast of 73.92 USD and a high forecast of 111.3 USD.
What is the Revenue forecast for MetLife Inc?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 3 years is 7%.
What is the Net Income forecast for MetLife Inc?
Projected CAGR
32%
Over the last 14 years, the compound annual growth rate for Net Income has been -5%. The projected CAGR for the next 3 years is 32%.
